INSPIREMD 1/18 DL-0001 (II2) - Total Liabilities
Based on the latest financial reports, INSPIREMD 1/18 DL-0001 (II2) has total liabilities worth €14.20 Million EUR (≈ $16.60 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore II2 shareholders equity momentum to track the company's year-over-year net asset growth rate.
INSPIREMD 1/18 DL-0001 - Total Liabilities Trend (2021–2025)
This chart illustrates how INSPIREMD 1/18 DL-0001's total liabilities have evolved over time, based on quarterly financial data.
INSPIREMD 1/18 DL-0001 Competitors by Total Liabilities
The table below lists competitors of INSPIREMD 1/18 DL-0001 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cohen & Company Inc
NYSE MKT:COHN
|
USA | $583.99 Million |
|
Shenzhen Zhongheng Huafa Co Ltd Class B
SHE:200020
|
China | HK$327.73 Million |
|
Hunyvers SA
PA:ALHUN
|
France | €75.34 Million |
|
Colorpak Indonesia Tbk
JK:CLPI
|
Indonesia | Rp268.13 Billion |
|
Imugene Ltd
AU:IMU
|
Australia | AU$25.80 Million |
|
Maskapai Reasuransi Indonesia
JK:MREI
|
Indonesia | Rp3.81 Trillion |
|
Jian Sin Industrial Co Ltd
TWO:4502
|
Taiwan | NT$1.74 Billion |
|
Asian Hotels (East) Limited
NSE:AHLEAST
|
India | Rs4.72 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down INSPIREMD 1/18 DL-0001's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see INSPIREMD 1/18 DL-0001 market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how INSPIREMD 1/18 DL-0001's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for INSPIREMD 1/18 DL-0001 (2021–2025)
The table below shows the annual total liabilities of INSPIREMD 1/18 DL-0001 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €14.20 Million ≈ $16.60 Million |
+32.48% |
| 2024-12-31 | €10.72 Million ≈ $12.53 Million |
+31.68% |
| 2023-12-31 | €8.14 Million ≈ $9.52 Million |
+12.15% |
| 2022-12-31 | €7.26 Million ≈ $8.49 Million |
+17.48% |
| 2021-12-31 | €6.18 Million ≈ $7.23 Million |
-- |
About INSPIREMD 1/18 DL-0001
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard c… Read more